- Previous Close
1.3600 - Open
1.3700 - Bid 0.9864 x 100
- Ask 1.6500 x 200
- Day's Range
1.2850 - 1.3750 - 52 Week Range
0.9100 - 4.4800 - Volume
382,130 - Avg. Volume
589,286 - Market Cap (intraday)
165.323M - Beta (5Y Monthly) 0.84
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3600 - Earnings Date May 7, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.58
The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.
www.beautyhealth.com769
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SKIN
View MorePerformance Overview: SKIN
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SKIN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SKIN
View MoreValuation Measures
Market Cap
165.32M
Enterprise Value
363.42M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.56
Price/Book (mrq)
3.19
Enterprise Value/Revenue
1.09
Enterprise Value/EBITDA
24.99
Financial Highlights
Profitability and Income Statement
Profit Margin
-8.70%
Return on Assets (ttm)
-5.25%
Return on Equity (ttm)
-52.34%
Revenue (ttm)
334.29M
Net Income Avi to Common (ttm)
-29.1M
Diluted EPS (ttm)
-0.3600
Balance Sheet and Cash Flow
Total Cash (mrq)
370.06M
Total Debt/Equity (mrq)
1,096.77%
Levered Free Cash Flow (ttm)
28.8M